Client News

InflaRx Announces November Investor Events

AL-S Pharma Reports New AP-101 Phase 2 Weight Data and Outlines Phase 3 Clinical Trial in ALS at 2026 NEALS Annual Meeting

InflaRx Highlights Izicopan’s Therapeutic Potential at Kidney Week 2026

Newron Completes Enrollment of Pivotal Phase 3 ENIGMA-TRS 1 Study

CorTec Brain Interface Electrodes Record Stable Signals for More Than Four Years

Formycon and Biocelys Combine Complementary Development and Manufacturing Expertise in New Biosimilar Project FYB286

Cellbox Solutions Completes Series A Financing with Total Proceeds of EUR 5 Million

invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal

BIOTECH SUMMIT AUSTRIA Highlights Growing Momentum Across Austria’s Biotech Sector

seragy Launches with €12 Million Financing to Advance Quantitative Biomarkers for Neurodegenerative Diseases